Suggestion

Princess of Wales photo controversy shows we’ve been thinking about edited images the wrong way

Retrieved on: 
Wednesday, March 13, 2024

Experts have warned of a coming “infocalypse”, and of the consequences for this year’s bumper crop of elections.

Key Points: 
  • Experts have warned of a coming “infocalypse”, and of the consequences for this year’s bumper crop of elections.
  • Yet the biggest story about photographic manipulation so far in 2024 is that the Princess of Wales manually edited a family portrait.
  • The response to this controversy can help us think about the wider challenge of manipulated images and video.

A royal history of faked photographs

  • Queen Victoria and Prince Albert were early enthusiasts, first sitting for photographs in the 1840s.
  • During this time, composite images – which combine multiple exposures into one image – were widespread, owing to the limitations of photographic technology.
  • Some of these composite photographs, such as Henry Peach Robinson’s image Fading Away, were controversial, because of both their subject matter and technique.
  • Before it became possible to directly print photographs in newspapers in 1880, there was a widespread practice of copying photographs into drawings, embellishing them by adding colour and improving the composition.
  • When half-tone printing was introduced, journalists continued to tweak their photographs, with one editor of a photography magazine in 1898 boldly stating that “everybody fakes”.

Solving a social problem

  • Outside of journalistic contexts, we don’t have strong social norms against adding colour to photographs.
  • The problem here isn’t that photo editing software fundamentally undermines our trust in photographs.
  • But the fact that we have those standards, and press organisations were able to respond accordingly, shows we have the tools to manage this problem.
  • But this is a social, not just a technological, problem.


Joshua Habgood-Coote has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 818633).

C.Wonder by Christian Siriano wins HSN’s Vendor Excellence Award for Rising Star

Retrieved on: 
Thursday, March 7, 2024

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company with expertise in livestream shopping and social commerce, announced today that their brand C. Wonder by Christian Siriano was awarded the HSN’s Vendor Excellence Award for Rising Star on February 28th, 2024.

Key Points: 
  • NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company with expertise in livestream shopping and social commerce, announced today that their brand C. Wonder by Christian Siriano was awarded the HSN’s Vendor Excellence Award for Rising Star on February 28th, 2024.
  • C. Wonder by Christian Siriano wins the Vendor Excellence Rising Star Award at HSN.
  • Launched in March 2023, under the creative direction of Christin Siriano, C. Wonder brings a playful exuberance to the HSN community.
  • In addition to C. Wonder by Christian Siriano, Xcel Brands owns TWRHLL by Christie Brinkley, Halston, Judith Ripka and LOGO by Lori Goldstein brands.

Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC

Retrieved on: 
Thursday, February 29, 2024

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today provided a clinical update on the first release of data from its second-line RAS-mutated metastatic colorectal cancer (mCRC) ONSEMBLE trial. Although the Phase 2 ONSEMBLE trial was discontinued as part of the company’s shift to a first-line mCRC program, it enrolled 23 patients randomized across three arms prior to closing the trial to new enrollment. The 23 enrolled patients continued treatment per protocol. The clinical data repeats the efficacy findings of onvansertib in bev naïve patients seen in the company’s earlier Phase 1b/2 KRAS-mutated mCRC trial.

Key Points: 
  • Although the Phase 2 ONSEMBLE trial was discontinued as part of the company’s shift to a first-line mCRC program, it enrolled 23 patients randomized across three arms prior to closing the trial to new enrollment.
  • The clinical data repeats the efficacy findings of onvansertib in bev naïve patients seen in the company’s earlier Phase 1b/2 KRAS-mutated mCRC trial.
  • “The randomized data from the ONSEMBLE trial further validates the opportunity for onvansertib in the first-line RAS-mutated mCRC setting.
  • We look forward to sharing the topline results of our first-line CRDF-004 trial in mid-2024.”
    In August 2023, Cardiff Oncology discontinued enrollment in the second-line ONSEMBLE trial to focus on its new lead program in first-line RAS-mutated mCRC.

Ibogaine Treatment May Be More Effective During the Month of March, According to David Dardashti

Retrieved on: 
Monday, February 26, 2024

MIAMI, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mental health advocate David Dardashti has suggested that the month of March may be the most effective time to undergo Ibogaine treatment.

Key Points: 
  • MIAMI, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mental health advocate David Dardashti has suggested that the month of March may be the most effective time to undergo Ibogaine treatment.
  • Ibogaine Treatment Dardashti, founder of the Ibogaine Center in Miami, believes that the month of March may be the most effective time to undergo this treatment due to the alignment of electric currents.
  • "My research suggests that the Ibogaine treatment may be more effective in March", says Dardashti.
  • Dardashti suggests that the Ibogaine treatment may be more effective during the month of March due to the stabilization of electric currents, allowing individuals to develop a stronger intuition and potentially aiding their recovery process.

Drug insurance: A single-payer pharmacare program would jeopardize coverage quality for 21 million Canadians

Retrieved on: 
Thursday, February 22, 2024

“All across the country, private drug insurance plans cover more treatments than governmental plans,” explains Emmanuelle B. Faubert, economist at the MEI and author of the study.

Key Points: 
  • “All across the country, private drug insurance plans cover more treatments than governmental plans,” explains Emmanuelle B. Faubert, economist at the MEI and author of the study.
  • Nearly 25 million Canadians have private drug insurance coverage.
  • Between 2018 and 2021, private drug insurance plans covered 51 per cent more drugs on average than public plans.
  • The MEI study indicates that even if a public plan as generous as Quebec’s were extended across the country, 21.5 million Canadians would risk seeing the quality of their insurance coverage fall.

Top Travel Trends Released by Visited App

Retrieved on: 
Thursday, February 22, 2024

TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Visited has published top 10 countries for South Korean travellers to visit.

Key Points: 
  • TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Visited has published top 10 countries for South Korean travellers to visit.
  • It has also published a travel report showcases popular destinations for 2023, and other travel trends.
  • Visited is available on iOS and Android apps for free, and is translated to over 30 languages.
  • The travel app Visited, allows user to map their travels, tick off places they have been to and discover new places to visit.

Steward Is Committed to Continuing to Work With Governor, Attorney General and State Regulators

Retrieved on: 
Wednesday, February 21, 2024

Let me first make crystal clear that Steward is committed to continuing to work with you and your Administration to ensure continuity of access to high-quality medical care in the communities we serve.

Key Points: 
  • Let me first make crystal clear that Steward is committed to continuing to work with you and your Administration to ensure continuity of access to high-quality medical care in the communities we serve.
  • Our commitment, and our accomplishments, are steadfast and ongoing: Steward hospitals and providers see approximately 1,500 patients every day.
  • You ask us in your letter to partner with your administration on three topics, which I will address in turn.
  • We look forward to continuing a productive dialogue with your Administration to effectuate this plan in short order.

Kwik Kar to Expand Nationwide Through Franchising, Rides 2023 Sales Momentum

Retrieved on: 
Tuesday, March 5, 2024

GREENWOOD VILLAGE, Colo., March 5, 2024 /PRNewswire/ -- Kwik Kar Oil Change & Auto Care,™ automotive aftermarket repair facility and flagship brand of FullSpeed Automotive®, announces its franchise opportunity after record sales growth. Kwik Kar® currently has 240 locations in Texas, and is primed to open 50 more locations nationwide over the next five years through franchising.

Key Points: 
  • Kwik Kar® currently has 240 locations in Texas, and is primed to open 50 more locations nationwide over the next five years through franchising.
  • Kwik Kar specializes in full-service oil changes, scheduled maintenance, state inspections, and many other automotive repair services.
  • The iconic Kwik Kar brand adds impressive strength to FullSpeed's current roster of flagship brands, which already includes Grease Monkey® and SpeeDee Oil Change & Auto Service®.
  • For more information on Kwik Kar and FullSpeed Automotive, visit kwikkarfranchise.com and fullspeedautomotive.com or call 800-364-0352.

DeNexus Streamlines Compliance to SEC Cybersecurity Regulation with Executive Cyber Risk Report

Retrieved on: 
Tuesday, February 27, 2024

BOSTON, Feb. 27, 2024 /PRNewswire/ -- DeNexus, a leader in end-to-end cyber risk quantification and management for operational technology (OT) and industrial control systems (ICS), today launched a turnkey solution for DeNexus users to report annually to the SEC on their cyber risk management and governance processes.

Key Points: 
  • The Executive Report and the cyber risk analyses detail an estimation of Annual Expected Losses and Value at Risk for compliance with SEC reporting.
  • "With this new SEC regulation emphasizing the need for detailed risk assessment and management, there is no better time for DeNexus to help our customers navigate the complexities of OT Cyber Risk Quantification and Management through unparalleled insights, enabling effective cyber risk management and strategic decision-making."
  • In addition to reporting cybersecurity incidents promptly, Article 106 of the new SEC cybersecurity regulation mandate U.S.-listed firms to disclose cybersecurity risk management and governance details in their annual 10-K filings.
  • To learn more about DeNexus SEC executive report, download our SEC brief here .

DIGITIMES Asia: Why TSMC may have different strategies in Japan and Arizona? Q&A with former TSMC General Counsel Richard Thurston

Retrieved on: 
Tuesday, February 27, 2024

Based on your experience in Japan and your work at TSMC, why is semiconductor manufacturing so successful in this part of Asia?

Key Points: 
  • Based on your experience in Japan and your work at TSMC, why is semiconductor manufacturing so successful in this part of Asia?
  • In Japan, pure-play foundries have not yet been successful, and making this business model work in Japan will be challenging.
  • Therefore, I've been in a unique position to observe the successful development of the semiconductor industry in these Asian countries.
  • Online Forum - TSMC Sparks Semiconductor Renaissance in Japan:
    Delve into "TSMC Sparks Semiconductor Renaissance in Japan" at our GeoWatch Webinar.